Argos Therapeutics Names Lee Allen Chief Medical Officer

Lee Allen has joined Argos Therapeutics (NASDAQ: [[ticker:ARGS]]) as the drug developer’s chief medical officer. Allen joins Durham, NC-based Argos as the company continues late-stage clinical trials on a cancer immunotherapy, AGS-003, in kidney cancer. Allen most recently served as chief medical officer for Nevada-based cancer drug company Spectrum Pharmaceuticals (NASDAQ: [[ticker:SPPI]]). His experience also includes executive positions with AMAG Pharmaceuticals, Wyeth Reseach, Pfizer, and BASF’s Knoll Pharmaceuticals.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan